Meta-analysis evaluates GLP-1 Receptor Agonists' impact on BMI, insulin resistance, and testosterone in Polycystic Ovary Syndrome
Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Abstract
GLP-1 Receptor Agonists' effects on BMI, HOMA-IR, and total testosterone in Polycystic Ovary Syndrome were assessed by a meta-analysis, but no quantitative results are reported in the abstract.